Introduction

Did you know that a child who never reaches puberty and cannot smell coffee may share a single genetic fault? That fault is known as the Kallmann syndrome (KS). KS is a rare developmental condition caused by the failure of nerve cells that control puberty and smell to reach their targets during early pregnancy.¹ It affects around one boy in 8,000 and one girl in 40,000.¹ More than twenty genes are now linked to KS, the most well-characterised of which include ANOS1, FGFR1, CHD7, PROK2 and PROKR2.² This article explains how the syndrome is inherited through three genetic mechanisms: X-linked, autosomal 

dominant and autosomal recessive inheritance. It also highlights the importance of determining the specific mode of inheritance for accurate diagnosis, treatment, and family planning.

Answering the main question

KS is said to be X-linked when a fault in the ANOS1 gene is located on the X chromosome; autosomal dominant occurs when a single faulty copy of genes such as FGFR1 or CHD7 is sufficient to cause the disease; or autosomal recessive happens when two faulty copies of genes such as PROKR2 or PROK2 are required. Each inheritance route alters the familial risk profile and necessitates a different genetic-counselling plan.^2,3,4,5

Read on

The following sections set out, one by one, the mechanism of each inheritance pattern, the genes involved, and clinical features that assist in diagnosis. Keep reading if you or someone close to you faces KS and needs clear answers.

X-linked Kallmann syndrome

Most cases of X-linked KS result from loss-of-function mutations in ANOS1 (formerly KAL1), located on Xp22.3.² Because males possess only one X chromosome, a single faulty copy stops the anosmin-1 protein from guiding olfactory and gonadotropin-releasing hormone (GnRH) neurones to the brain. The result is absent or delayed puberty, very low sex hormones, and severe hyposmia or complete anosmia. Carriers are almost always female and may experience only mild or no olfactory impairment at all because their second X chromosome supplies adequate functional protein. A carrier mother has a 50 % chance of passing the faulty gene to each son (who will be affected) and a 50 % chance of passing it to each daughter (who will then be a carrier). Fathers never transmit an X-linked mutation to their sons. Renal agenesis, mirror movements of the hands (synkinesia), and unilateral sensorineural deafness can accompany the classic picture reflecting the broader developmental roles of anosmin-1 in neuronal guidance beyond the brain.²

Autosomal dominant Kallmann syndrome

Autosomal dominant KS needs only one faulty copy of a causative gene. The flagship example is FGFR1. Loss-of-function mutations in FGFR1 provided the first evidence that disturbed fibroblast growth-factor signalling can block GnRH-neurone migration.³ A second key gene CHD7, was first linked to KS in 2008 following studies on patients with mild features of CHARGE syndrome.⁵ Additional autosomal dominant genes include FGF8, SOX10 and SEMA3A. Unlike the X-linked form, autosomal dominant KS affect males and females equally. Penetrance is incomplete: some carriers may exhibit only partial puberty, isolated anosmia, or even remain outwardly healthy. Variable expression can result in one sibling requiring testosterone replacement while another requires only reassurance. The autosomal dominant route also explains most syndromic cases where KS accompanies cleft lip, hearing loss, or dental agenesis. Each child of an affected parent has a 50 % risk of inheriting the mutation.

Autosomal recessive Kallmann syndrome

When KS is recessive, both alleles of a gene must be faulty. The two principal genes implicated are PROKR2 and its ligand PROK2, which regulate chemotactic signals for GnRH and olfactory axons. In 2006, Dodé and colleagues found biallelic PROKR2 or PROK2 variants in patients with classic KS.⁴ Parents who carry one faulty copy are healthy. If both parents carry the same recessive variant, each child has a 25 % chance of being affected, a 50 % chance of being a carrier and a 25 % chance of inheriting two healthy copies. Recessive KS often appears in consanguineous families or isolated communities where carriers marry each other by chance. Compound heterozygosity (two different variants in the same gene) is common. The phenotype can be milder than in X-linked disease; some men achieve partial virilisation without treatment, and some women may menstruate sporadically.

Oligogenic and “mixed” inheritance

Roughly one-third of patients show variants in more than one gene, confirming that KS can be oligogenic. A person may carry a dominant FGFR1 variant plus a recessive PROKR2 change, tipping the developmental balance towards disease.⁴ This blurs the classic categories and explains why genetic test results do not always match the pedigree. Clinicians now screen broad gene panels and interpret results with caution, using segregation analysis within the family.

Genetic testing and counselling

Modern testing starts with a multi-gene next-generation sequencing panel that covers all known KS genes. Copy-number analysis is added when X-linked disease is suspected. Once a pathogenic variant is found, relatives can be offered targeted tests. Early diagnosis lets boys start testosterone or gonadotropin therapy in mid-teens, preventing low bone density and poor muscle bulk, and lets girls start oestrogen replacement to trigger secondary sexual traits. When fertility is desired, pulsatile GnRH or combined gonadotrophins can induce spermatogenesis or ovulation in most patients. Couples receive personalised risk figures: 50 % per pregnancy for dominant disease, 25 % for recessive disease and gender-specific risks for X-linked disease. Pre-implantation genetic testing is an option if both partners wish to avoid passing KS to children.

FAQs

Is every case of delayed puberty caused by Kallmann syndrome?

No. KS is rare. Most delayed puberty is self-limited. Loss of smell is the key clue that points to KS.¹

Can a woman with Kallmann syndrome become pregnant?

Yes. With gonadotropin injections or pulsatile GnRH therapy, many women ovulate and conceive.²

Why does my brother have Kallmann syndrome when I do not?

If the mutation is X-linked, a brother who inherits the faulty X will be affected, while a brother who receives the normal X will be healthy. Sisters usually become carriers. In dominant KS, the difference is due to incomplete penetrance.

Should children in the family be tested?

Testing is advised before the expected age of puberty so that hormone treatment can start on time. The exact test depends on the mutation identified in the first affected person.

Summary

Kallmann syndrome stops puberty and dulls the sense of smell because key neurones fail to reach the brain during development. It moves through families in three main ways. X-linked disease comes from ANOS1 mutations and mainly affects boys. Autosomal dominant disease arises from single-copy defects in genes such as FGFR1 or CHD7 and shows variable expression in both sexes. Autosomal recessive disease needs two faulty copies of genes, such as PROKR2 or PROK2 and often appears when parents are related. Knowing the route lets clinicians choose the right genetic test, give clear reproductive advice and start timely hormone therapy.